Non-Current Assets
PP&E (Gross)
Moderna PP&E (Gross) increased by 0.3% to $2.88B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.7%, from $2.78B to $2.88B. Over 5 years (FY 2020 to FY 2025), PP&E (Gross) shows an upward trend with a 47.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026May 1, 2026
Parent metricPP&E (Net)
How to read this metric
An increase indicates ongoing capital investment and expansion of physical capacity; a decrease suggests asset disposals or a shift toward asset-light models.
Detailed definition
This represents the total historical cost of all tangible long-lived assets, such as buildings, machinery, and equipment...
Peer comparison
Standard across capital-intensive industries; peers report this as 'Gross Property, Plant, and Equipment'.
Metric ID:
ppe_total_grossHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $998.00M | $1.12B | $1.59B | $1.77B | $1.79B | $2.60B | $2.68B | $2.75B | $3.11B | $3.02B | $2.38B | $2.53B | $2.70B | $2.93B | $2.72B | $2.78B | $2.79B | $2.80B | $2.87B | $2.88B |
| QoQ Change | — | +12.1% | +42.4% | +11.2% | +1.0% | +45.2% | +3.0% | +2.9% | +12.8% | -2.6% | -21.4% | +6.3% | +6.8% | +8.6% | -7.1% | +2.0% | +0.5% | +0.2% | +2.6% | +0.3% |
| YoY Change | — | — | — | — | +79.4% | +132.3% | +68.0% | +55.4% | +73.5% | +16.4% | -11.1% | -8.2% | -13.1% | -3.0% | +14.5% | +9.9% | +3.4% | -4.6% | +5.4% | +3.7% |
| % of PP&E (Net) | 125.7% | 132.4% | 128.4% | 132.1% | 135.2% | 128.7% | 132.6% | 136.5% | 136.2% | 154.9% | 122.3% | 122.5% | 123.0% | 123.1% | 124.0% | 125.6% | 128.7% | 131.6% | 134.5% | 138.1% |
| Share Change | — | +6.7pp | -4.1pp | +3.8pp | +3.1pp | -6.5pp | +3.9pp | +3.9pp | -0.2pp | +18.7pp | -32.7pp | +0.3pp | +0.4pp | +0.2pp | +0.9pp | +1.6pp | +3.1pp | +2.8pp | +3.0pp | +3.5pp |
Range$998.00M – $3.11B
CAGR+25.0%
Avg YoY Growth+26.4%
Median YoY Growth+7.7%
Current Streak5 quarters growth
PP&E (Gross) at Other Companies
Frequently Asked Questions
- What is Moderna's pp&e (gross)?
- Moderna (MRNA) reported pp&e (gross) of $2.88B in Q1 2026.
- How has Moderna's pp&e (gross) changed year-over-year?
- Moderna's pp&e (gross) increased by 3.7% year-over-year, from $2.78B to $2.88B.
- What is the long-term trend for Moderna's pp&e (gross)?
- Over 5 years (2020 to 2025), Moderna's pp&e (gross) has grown at a 47.1% compound annual growth rate (CAGR), from $417.00M to $2.87B.
- What does pp&e (gross) mean?
- The total original cost of all physical assets like buildings and equipment before subtracting depreciation.